Elongation Factor RNA Polymerase II (ELL) (Middle Region) Peptide
-
- Target See all ELL products
- ELL (Elongation Factor RNA Polymerase II (ELL))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ELL antibody (Catalog #: ARP30106_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ELL (Elongation Factor RNA Polymerase II (ELL))
- Synonyms
- wu:fc60b11 Peptide, zgc:63836 Peptide, C19orf17 Peptide, ELL1 Peptide, MEN Peptide, PPP1R68 Peptide, Ell1 Peptide, Men Peptide, elongation factor for RNA polymerase II Peptide, elongation factor RNA polymerase II Peptide, ELL Peptide, ell Peptide, Ell Peptide
- Background
-
ELL ia an elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA.
Alias Symbols: C19orf17, DKFZp434I1916, ELL1, Men, MEN, PPP1R68
Protein Interaction Partner: EAF1,EAF2,HNRNPU,POLR2A,SNF8,TFPT,TP53,EAF1,EAF2,SIRT2,SNF8,TP53,USPL1,ZHX1
Protein Size: 621 - Molecular Weight
- 68 kDa
- Gene ID
- 8178
- NCBI Accession
- NM_006532, NP_006523
- UniProt
- P55199
-